Ultrasound during the COVID-19 Pandemic: A Global Approach.
Anna LombardiMariarosaria De LucaDario FabianiFrancesco SabatellaCarmen Del GiudiceAdriano CaputoLuigi CanteMichele GambardellaStefano PalermiRita TavarozziVincenzo RussoAntonello D'AndreaPublished in: Journal of clinical medicine (2023)
SARS-CoV-2 (severe acute respiratory syndrome Coronavirus-2) rapidly spread worldwide as COVID-19 (Coronavirus disease 2019), causing a costly and deadly pandemic. Different pulmonary manifestations represent this syndrome's most common clinical manifestations, together with the cardiovascular complications frequently observed in these patients. Ultrasound (US) evaluations of the lungs, heart, and lower limbs may be helpful in the diagnosis, follow-up, and prognosis of patients with COVID-19. Moreover, POCUS (point-of-care ultrasound) protocols are particularly useful for patients admitted to intensive care units. The present review aimed to highlight the clinical conditions during the SARS-CoV-2 pandemic in which the US represents a crucial diagnostic tool.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- magnetic resonance imaging
- end stage renal disease
- intensive care unit
- ejection fraction
- heart failure
- chronic kidney disease
- pulmonary hypertension
- ultrasound guided
- peritoneal dialysis
- contrast enhanced ultrasound
- prognostic factors
- case report
- mechanical ventilation
- patient reported outcomes
- computed tomography
- patient reported